Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.45 |
| ▸ | S100B | P04271 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1129966 | 1.00 | KMT2A (0.59) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL19233521 | 0.98 | KMT2A (0.62) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL31351734 | 0.93 | KMT2A (0.49) | KMT2ARAB9AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL31351777 | 0.93 | KMT2A (0.49) | KMT2ARAB9AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL3585089 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL4891605 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL4891614 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL3585101 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL13368811 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B | |
| SCHEMBL3585094 | 0.86 | RAB9A (0.52) | KMT2ARAB9ANPC1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3707132-B1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | UNIV PARIS SACLAY (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | Universite Paris-Saclay (FR) | 2021-06-15 | — | — | US | disclosed |
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | Universite Paris-Saclay (FR) | 2020-08-13 | — | — | US | disclosed |
| WO-2019063952-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | UNIVERSITE PARIS-SUD (FR) | 2019-04-04 | — | — | WO | disclosed |
| US-8158135-B2 | Imine based liquid crystals for the controlled release of bioactive materials | FIRMENICH SA (CH) | 2012-04-17 | — | — | US | disclosed |
| EP-2010231-B1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH & CIE (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2009-12-10 | — | — | US | disclosed |
| EP-2010231-A2 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | Firmenich S.A. (CH) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007113711-A2 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | ADH1C, ADH1A, ADH5 | KMT2A 1195/4885RAB9A 2970/4885NPC1 2597/4885 |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | ADH1C, PNMT, ADH1A | KMT2A 1042/4885RAB9A 3133/4885NPC1 2477/4885 |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | BCHE, ACHE, LIPE | KMT2A 4535/4885RAB9A 1589/4885NPC1 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.